Maze Therapeutics (MAZE) Times Interest Earned (2026)

Maze Therapeutics has reported Times Interest Earned for 3 years, with the latest figure at $7.09 in Q1 2026.

• Quarterly Times Interest Earned changed N/A year-over-year to $7.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.78 (changed N/A YoY) and the FY2025 annual result came in at -$0.87, down 233.77% from the prior year.
• Times Interest Earned advanced to $7.09 in Q1 2026 per MAZE's latest filing, from -$0.34 in the prior quarter.
• Over five years, Times Interest Earned peaked at $7.09 in Q1 2026 and troughed at -$60.17 in Q4 2024.
• A 3-year average of -$17.81 and a median of -$0.34 in 2025 frame the typical range for Times Interest Earned.
• The widest YoY moves for Times Interest Earned: up 99.44% in 2025, down 99.44% in 2025.
• Over 3 years, Times Interest Earned stood at -$60.17 in 2024, then soared by 99.44% to -$0.34 in 2025, then soared by 2185.96% to $7.09 in 2026.
• According to Business Quant data, Times Interest Earned over the past three periods registered $7.09, -$0.34, and -$60.17 for Q1 2026, Q4 2025, and Q4 2024 respectively.